Why Staging TED Correctly Matters Even When CAS Is Low
Andrea Lora Kossler, MD, FACS
Kimberly Cockerham, MD
Understanding IGF-1R Inhibition: Mechanism & Clinical Implications
Prem S. Subramanian, MD, PhD
Applying CAS, EUGOGO, VISA: A Micro Case
Comparing Trial Designs & Outcomes Across IGF-1R Therapies
Why QoL Measures Change TED Management
Beyond IGF-1R: IL-6R Inhibition and Future Sequencing
Advancing Uveitis Care: Emerging Challenges and Research Opportunities
Steven Yeh, MD, FASRS
Vitreous Sensing Vitrectomy
Maria Berrocal
Jordan D. Deaner, MD
Observation vs. Vitrectomy for Floaters
Kyle Davis Kovacs, MD
Matthew Starr, MD
Nita Valikodath, MD, MS
Choosing the Right Therapy for RVO Patients
Michael Javaheri, MD, MSc, FASRS
Balancing Urgency and Outcomes in Macula-Off Retinal Detachment Surgery
Akshay Thomas, M.D., M.S., FASRS
Emerging Focus in NAION: Sharpening Diagnostic Precision for Tomorrow’s Treatments
Andrew G. Lee, MD
Valerie Biousse, MD
Ischemic vs. Non-Ischemic RVO: How Do You Know?
Jessica Randolph, MD
Personalized Patient-Centered Glaucoma Management
Inder Paul Singh
Lorraine M. Provencher, MD
Zarmeena Vendal, MD
Manjool Shah, MD
Emily Schehlein, MD
Swarup Swaminathan, MD
New Contact Lens Technology for Patients With Presbyopia, Dry Eye Disease, and Ocular Surface Disease
Melissa Barnett
Racial/Ethnic Disparities in TDR, DME, and Other Vision Threats in Patients With DR
Jordan Deaner
Vaidehi S. Dedania, MD
Rehan M. Hussain, MD
Loading...
We're glad to see you're enjoying Eye Health Academy… but how about a more personalized experience?
Press cancel to remain on Eye Health Academy. Press the link below or the continue button to keep going.